XML 71 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Legal Matters (Details) (Pending litigation, USD $)
6 Months Ended 0 Months Ended 0 Months Ended 6 Months Ended
Jun. 30, 2013
License agreement with Genentech - EYLEA
Dec. 31, 2012
License agreement with Genentech - EYLEA
United States
Sep. 25, 2012
First Davis Smyth Case [Member]
claim
Sep. 21, 2012
First Davis Smyth Case [Member]
claim
Jan. 17, 2012
First Davis Smyth Case [Member]
claim
Dec. 23, 2011
Second Davis Smyth Case [Member]
claim
Jun. 30, 2013
License agreement with Genentech - ZALTRAP
Global
May 17, 2013
License agreement with Genentech - ZALTRAP
Global
Loss Contingencies [Line Items]                
Payment made or may be made upon reaching minimum sales target   $ 60,000,000           $ 19,000,000
Cumulative Relevant Sales 400,000,000           200,000,000  
Sales Range Minimum 400,000,000           400,000,000  
Royalty Payment Percentage Of Cumulative Sales Within Range 4.75%           4.50%  
Sales Range Maximum 3,000,000,000           1,000,000,000  
Royalty Payment Percentage Of Sales Over Range 5.50%           6.50%  
Cumulative Sales Range 2nd Tier $ 3,000,000,000           $ 1,000,000,000  
Loss Contingency, Pending Claims, Number         4      
Loss Contingency, New Claims Filed, Number     1 2   4